At the time of writing, Wave Life Sciences Ltd. [WVE] stock is trading at $5.86, saw in change for the day. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WVE shares have gain 14.23% over the last week, with a monthly amount glided 5.21%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Wave Life Sciences Ltd. [NASDAQ: WVE] stock has seen the most recent analyst activity on September 09, 2024, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $10. Previously, Wells Fargo started tracking the stock with Overweight rating on May 15, 2024, and set its price target to $11. On December 19, 2023, upgrade upgraded it’s rating to Outperform and revised its price target to $12 on the stock. Raymond James started tracking the stock assigning a Outperform rating and suggested a price target of $7 on July 05, 2023. Jefferies downgraded its rating to a Hold and reduced its price target to $5 on May 24, 2023. In a note dated October 23, 2020, RBC Capital Mkts initiated an Sector Perform rating and provided a target price of $13 on this stock.
For the past year, the stock price of Wave Life Sciences Ltd. fluctuated between $3.50 and $7.67. Currently, Wall Street analysts expect the stock to reach $14 within the next 12 months. Wave Life Sciences Ltd. [NASDAQ: WVE] shares were valued at $5.86 at the most recent close of the market. An investor can expect a potential return of 138.91% based on the average WVE price forecast.
Analyzing the WVE fundamentals
According to Wave Life Sciences Ltd. [NASDAQ:WVE], the company’s sales were 110.50M for trailing twelve months, which represents an -10.92% plunge. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.76%, Pretax Profit Margin comes in at -0.67%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -6.58 and Total Capital is -2.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 6.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.76 points at the first support level, and at 5.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.97, and for the 2nd resistance point, it is at 6.07.
Ratios To Look Out For
It is important to note that Wave Life Sciences Ltd. [NASDAQ:WVE] has a current ratio of 0.99. As well, the Quick Ratio is 0.99, while the Cash Ratio is 0.89. Considering the valuation of this stock, the price to sales ratio is 6.62.
Transactions by insiders
Recent insider trading involved BOLNO PAUL, President and CEO, that happened on Aug 21 ’24 when 48366.0 shares were sold. Officer, PAUL BOLNO completed a deal on Aug 21 ’24 to buy 48366.0 shares. Meanwhile, Chief Financial Officer Moran Kyle sold 15630.0 shares on Apr 03 ’24.
